2948 Articles37 Trusted SourcesUpdated Daily

Curated content, insights and a knowledge base for pricing and commercial strategy enthusiasts.

Topics
······
Content
||||
Disrupt Africa

Morocco’s One Med Link is developing an AI-powered workflow, health-data platform

Moroccan e-health startup One Med Link is developing an AI-powered, interoperable clinical workflow and health-data platform. Co-founded last year by co-founded by Deyaa Wahbi and Soukaina Benabid, One Med Link supports healthcare professionals across several parts of their daily workflow, including clinical documentation, medical summaries, structured patient information, clinical scores and decision-support tools, prescription-related workflows, [...] The post Morocco’s One Med Link is developing an AI-powered workflow, health-data platform appeared first on Disrupt Africa .

Start Ups·Global·8 Sept 2026·Article·AfricaRead full article →
The Bridge JP

BeyondUS Conducts Third-Party Allotment to Expand Remote Medical Platform “AmaneCare”

BeyondUS, which develops and provides remote medical platforms and medical knowledge AI, announced on the 7th that it has conducted a third-party allotment with S-Innovation (Regional Innovation Tech Niigata No. 1 Investment Business Limited Partnership) as the underwriter. The amount raised has not been disclosed. The company is engaged in the remote medical platform “AmaneCare,” the medical knowledge AI platform “MONJU,” and the back-office DX service “MedOptima.” According to BeyondUS, AmaneCare is aimed at medical institutions, MONJU targets medical students and healthcare professionals to streamline the organization and dissemination of knowledge through AI, and MedOptima is a service for medical and educational institutions. The company plans to co

Start Ups·APAC·8 Sept 2026·ArticleRead full article →
The Bridge JP

ANRis Raises Approximately ¥2.2 Billion for siRNA Design Technology to Identify Single Nucleotide Variations

ANRis, a company developing siRNA sequence design technology to selectively suppress mutant genes, announced on the 7th that it has raised a total of approximately ¥2.2 billion from Waseda University Ventures (WUV) and the Japan Science and Technology Agency (JST). Read more. The company’s core technology, “SNPD-siRNA (Single Nucleotide Polymorphism-Distinguishable siRNA),” is a sequence design technology that identifies single nucleotide differences between wild-type and mutant genes, selectively suppressing the expression of mutant genes that cause diseases. siRNA works by binding to target mRNA and suppressing its function, thereby reducing the amount of corresponding protein produced. ANRis aims to suppress mRNA containing single nucleotide mutations through its desig

Start Ups·APAC·8 Sept 2026·ArticleRead full article →
Academy of Management Journal

When Entrepreneurs Can’t Acknowledge Failure, Disaster Strikes

By Daniel Butcher Elizabeth Holmes, who was convicted of fraud for lying about the effectiveness of the blood-testing product of her biotechnology company, Theranos, is a cautionary tale illustrating a potential downside of entrepreneurship. Unable to deal with the failure of her company’s blood-testing methods, she just plowed ahead, refusing to acknowledge the disappointing results […] The post When Entrepreneurs Can’t Acknowledge Failure, Disaster Strikes appeared first on Academy of Management Today .

Business Strategy·US·7 Sept 2026·Article·Management JournalRead full article →
Showing 1-20 of 2894